Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Comabella

Showing results (81-90 of 263) with videos related to

Pageof 27
Sort By:
Molecular & Cellular Proteomics : MCP|November 11, 2015
Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple SclerosisEva Borràs, Ester Cantó, Meena Choi, et al.
Clinical and Translational Medicine|December 10, 2024
Chitinase 3-like 1 is neurotoxic in multiple sclerosis patient-derived cortical neuronsRucsanda Pinteac, Jordi Soriano, Clara Matute-Blanch, et al.
Journal of Neuroinflammation|November 20, 2014
Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosisEster Cantó, Mar Tintoré, Luisa Maria Villar, et al.
Journal of Neuroimmunology|January 9, 2017
Chitinase 3-like 1 is associated with the response to interferon-beta treatment in multiple sclerosisClara Matute-Blanch, Jordi Río, Luisa M Villar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2014
Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patientsJordi Río, Alex Rovira, Mar Tintoré, et al.
Scientific Reports|November 2, 2021
Genetic variation in NDFIP1 modifies the metabolic patterns in immune cells of multiple sclerosis patientsPilar López-Cotarelo, Adela González-Jiménez, Teresa Agudo-Jiménez, et al.
Annals of Neurology|June 18, 2026
Proinflammatory Epstein-Barr Virus Antibody Functions Track with Disease Activity in Multiple SclerosisMalina Behrens, Paula Terroba-Navajas, Eline A J Willemse, et al.
Stem Cells Translational Medicine|January 17, 2015
Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegenerationJoshua C Orack, Michela Deleidi, David Pitt, et al.
Human Molecular Genetics|November 26, 2015
MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changesManuel Comabella, Ester Cantó, Ramil Nurtdinov, et al.
Annals of Neurology|October 27, 2011
Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosisMarta F Bustamante, Nicolás Fissolo, Jordi Río, et al.
Pageof 27

Showing results (81-90 of 263) with videos related to

Sort By:
Pageof 27
Molecular & Cellular Proteomics : MCP|November 11, 2015
Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple SclerosisEva Borràs, Ester Cantó, Meena Choi, et al.
Clinical and Translational Medicine|December 10, 2024
Chitinase 3-like 1 is neurotoxic in multiple sclerosis patient-derived cortical neuronsRucsanda Pinteac, Jordi Soriano, Clara Matute-Blanch, et al.
Journal of Neuroinflammation|November 20, 2014
Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosisEster Cantó, Mar Tintoré, Luisa Maria Villar, et al.
Journal of Neuroimmunology|January 9, 2017
Chitinase 3-like 1 is associated with the response to interferon-beta treatment in multiple sclerosisClara Matute-Blanch, Jordi Río, Luisa M Villar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2014
Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patientsJordi Río, Alex Rovira, Mar Tintoré, et al.
Scientific Reports|November 2, 2021
Genetic variation in NDFIP1 modifies the metabolic patterns in immune cells of multiple sclerosis patientsPilar López-Cotarelo, Adela González-Jiménez, Teresa Agudo-Jiménez, et al.
Annals of Neurology|June 18, 2026
Proinflammatory Epstein-Barr Virus Antibody Functions Track with Disease Activity in Multiple SclerosisMalina Behrens, Paula Terroba-Navajas, Eline A J Willemse, et al.
Stem Cells Translational Medicine|January 17, 2015
Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegenerationJoshua C Orack, Michela Deleidi, David Pitt, et al.
Human Molecular Genetics|November 26, 2015
MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changesManuel Comabella, Ester Cantó, Ramil Nurtdinov, et al.
Annals of Neurology|October 27, 2011
Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosisMarta F Bustamante, Nicolás Fissolo, Jordi Río, et al.
Pageof 27